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1.1.  Theme description 
The objective of this work, namely of its theoretical part, was to sum up basic 
information about liquor /its  development, formation, composition, its basic 
and more detailed examination in clinical  practice/.   
A brief description of liquorological cytological findings including picture 
documentation.  
This work is in more details dedicated to protein beta2-microglobulin.  
The introduction brings an abstract of essential description of a molecule of 
this protein as well as a brief account of its examination. The importance of 
its examination. 
The following part  shows methods applied worldwide for this protein 
examination, the importance of its  examination, and conclusions of works 
published in connection with its  examination in different diseases.  
Conclusions from researches and their importance on establishing the 
diagnoses, treatment and further prognoses in various nosological units  – e.g. 
in HIV positive patients – have been summarized specifying therapy, 
prognosis in patients with degenerative CNS disease,  inflammatory disease… 
The follow-up itself was carried out in a large group of patients – in total 
26,378 liquor samples taken between 1999 – 2006, the age limit ranging from 
3 to 86 years.  
Samples were taken practically all over the whole Czech Republic and 
elaborated in a biochemical laboratory Na Homolce.  
This large group of patients was divided into 4 essential  groups according to 
their diagnoses:  
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Demylinisation disease, neuroboreliosis, tumours, CNS, others /standard 
findings and other diagnoses e.g. degenerative disease,  vertebrogenous 
disease/ .  
An average value of beta2-microglobulin and standard deviation was 
calculated in individual groups.  
Levels of this protein were compared between groups of men and women, at  
age groups / provided it was possible to compare and statistically compile the 
values in individual age groups/ .  
The outcomes were worked into a graphical form.  
Conclusion of this work provides a total summarization of the research – the 
importance of examination of beta2-microglobulin, comparison of protein 
levels in individual groups according to their diagnoses. The highest values 
are reached by beta2-microglobulin in the group of tumorous diseases. On 
significantly high values CNS tumorous disease might be directly considered 
and further examination procedures might be aimed at this direction.  
The level of beta2-microglobulin is  very near standard values in 
demyelinisation diseases.   
A different level in men and women can be found in physiological findings.  
The extension of the group provides a considerable predicative value – thus 
no random results  are in question.  
Findings of this work is definitely not negligible and it  makes its way for the 
following researches and comparisons of behaviour of this significant protein.  
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1.2.  Biological behaviour of beta2-microglobulin in liquor in clinically 
defined nosological units 
Under physiological conditions liquor is a colourless clear liquid found in the 
ventrical system of the brain, in cisterns and subarachnoidal areas of the brain 
and medulla.  
It  is produced in chorioidal  plexes. It  circulates on from both lateral chambers  
through foramen Monroi into the IIIrd chamber and through Sylvius ductulus 
into the IVth chamber. From there i t  flows through foramina Luschkae into 
pontocerebellar cornua and through foramen Magendi into cerebromedular 
cistern. Liquor is resorped in Pacchion granulations and dural sinus into 
venous circulation.  
Functions of  l iquor: 
1.  mechanical protection of the brain and medulla against  concussions… 
2.  levelling/balancing intracranial and intravertebral pressure ratios with 
venous system 
3.  function of regulation and protection on changes of temperature and 
atmospheric pressure 
4.  metabolisms of neurons,  removal of products of catabolism 
5.  immunological processes 
An average amount of liquor in adult  is about 140 ml, its average daily 
production is  about 500 ml.  
Most often lumbal punction is used for taking the liquor. The liquor is taken 
into 3 test tubes at  minimum. 
• Examination  
• – acute -  macroscopic description, total  protein, cytology, lactate 
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• primary – macroscopic description, general protein, cytology, lactate and 
glucoses,  albumin, IgA, IgG, IgM, oligoclonal IgG in liquor and serum, 
specific antidote indexes, number of erytrocytes and presence of  
haemoglobin 
• extended – PCR on HSV encephalitis  suspicion, tb,  CMV infection, 
tumour marker, CNS proteins quantification 
Metabolism among blood, liquor and nerve tissue is  regulated by barriers 
creating 4 compartments:  
1.  intravascular 
2.  intracellular 
3.  extracellular 
4.  liquor 
There are the following barrier systems among individual compartments:  
1.  haematoencephalic barrier 
2.  haematoliquor barrier 
3.  intra/extracellular barrier 
 
1.3.  Biochemical liquor examination 
The examination spectrum has st ill  been expanding as a result  of development 
of laboratory methodologies.  
In principle, the following should be examined: 
• total /general protein level  
• glucose level  
• immunoglobulin and albumin level  assessment 
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• acute phase proteins assessment 
In addition, in extended examination also structural CNS proteins are 
examined /gamma trace protein, basic/alkaline myelin protein, beta trace 
protein, tau protein…/ 
Immunoglobulins are assessed by electrophoretic separating methods – 
isoelectric focusing. 
Based upon the consensus 5 types of potential  outcomes on pairing/matching 
analysis of liquor and serum have been suggested:  
1.  standard liquor 
2.  oligoclonal IgG only in liquor 
3.  oligoclonal IgG in liquor and other identical bands in serum 
4.  identical  oligoclonal bands in liquor and serum  
5.  monoclonal bands in liquor and serum 
 
1.4.  Liquor spectrophotometric examination 
This examination provides information on presence of haematogenous 
pigments in liquor.  It  is important in haemorrhaegic incidence. It  helps 
differentiate  presence of arteficial bleeding. 
 
1.5.  Liquor cytology 
Cells in liquor are presumably of haemal origin. Under standard 
circumstances there occur 2 cell types in liquor: lymphocytes, monocytes.  
Erytrocytes and neutrophil  granulocytes are present only as a result of 
arteficial haemal admixture.  
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Characteristic cytological  pictures in different  clinical  units have been 
described. 
 
1.6.  Beta2–microglobulin 
Beta2–microglobulin is a low-molecular protein made of 99 amino-acids the 
sequence of which is known. It  has an internal disulphidic bond and thus it  
creates a loop smyčka. It forms a light  invariable chain of histocompatible 
antigens /HLA of Ist class/ against which the post-transplantation 
immunological intervention is focused.  
HLA are synthesised by all vital nuclear body cells in different intensity and 
located on their cellular surface. They cannot be found on erythrocytes.  
There is non-covalent bond between beta2-microglobulin and heavy HLA 
strand; as a result of metabolism and HLA degradation i t  is dissociated from 
heavy chains and then it  occurs in a free form in extracellular liquid and in 
all body fluids, whereas heavy HLA chain is readily degraded. 
Beta2-microglobulin level in serum is increasing in different states – in 
tumours,  inflammations,  immunological  diseases, renal fai lure,. . . .  
Great many studies quantifying beta2-microglobulin in liquor in connection 
with treatment of HIV positive patients, CNS infectious diseases and 
degenerative diseases have been published. 
 
2. OBJECTIVE OF THIS WORK 
To give reason for examination of beta2-microglobulin level  in liquor;  
To elucidate the nature of this protein in a theoretical  part  as well as upon 
own investigation/monitoring. 
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To try to find out whether beta 2-microglobulin level depends on a certain 
nosological unit; whether the level  of this protein depends on gender and age.  
To support  beta2-microglobulin examination in liquor in all taken samples.  
 
3. MATERIAL AND METHODOLOGY 
Between 1999 and 2006 a biochemical  laboratory Na Homolce examined 
23,432 samples of liquor taken from patients from practically all  over the CR.  
Different general diagnoses were established - meningitis/serous, bacterial/,  
demyelinisation disease, tumours, polyneuropathy, polyradiculoneuritis… 
Samples from patients with vertebrogenous diseases /where there were 
physiological  findings in liquor/ were used as a control  group. 
Diagnosis confirmation: liquor immunoelectrophorezis, determination of 
antibodies, CNS morphological  examination. 
 
3.1.  Methodology: 
Beta2–microglobulin level  was examined by immuno-turbidimetric method, 
i .e. monitoring the growth of opacity on bond of an antibody to beta2-
microglobulin. Monitoring was carried out on SYNCHRON LX 20 analyser 
from Beckman company. Applied chemicals were from Bio-Vendor ČR 
company. 
 
3.2.  Statistical processing 
It  was based on calculation the average values and standard deviations.  
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4. RESULTS 
The file of samples being monitored was made of 26,378 samples of patients 
at the age ranging from 3 to 86 years the liquor of whom was examined in a 
biochemical  laboratory Na Homolce between 1999 – 2006. 
 
The file was divided into the groups according to their diagnoses:  
1.  demyelinisation disease – RSM 
2.  neuroboreliosis 
3.  tumours 
4.  others 
An average level  of beta2-microglobulin and standard deviation was 
calculated in the examination. Further on, the results of age categories and 
those of men and women were compared.  
Individual groups and results were also compared in graphs/charts.  
 
4.1.  Demyelinisation disease  -  RSM 
The group consists of 8,652 examined samples.  
The average value of beta2- microglobulin in liquor is  1.885; standard 
deviation 0.917. 
No relation to gender has been proved, age relation seems possible.  
 
4.2.  Neuroboreliosis 
The group consists of 1,312 examined samples.  
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The average value of beta2 –microglobulin in liquor is 2.485; standard 
deviation 5.580 
No relation to gender, in children – higher average value of beta2 – 
microglobulin.  
 
4.3.  Tumours 
The group consists of 186 examined samples.  
The average value of beta2- microglobulin in liquor is  3.202; standard 
deviation 2.715. 
Relation to gender seems proved, lower average value of beta2-microglobulin 
at lower age categories.  
 
4.4.  Standard findings 




The results confirm difference of beta2- microglobulin level in individual 
groups.  
The highest levels have been found in the group with tumours.  
In the group of demyelinisation diseases the values are very near standard 
values. In this type of disease /provided plasmocytes are not recorded in 
cytological preparation/ the findings is also near the standard.  Final diagnosis 
is established with the help of electrophoresis. Does the level of beta2- 
microglobulin also depend on the state of the disease? Could the success rate 
MUDr.  Jana Svatoňová  Autoreport  for  Disser ta t ion Work 
B io logica l  behaviour  o f beta2-microglobul in in  l iquor  
 in c l in ica l ly defined nosologica l  unit s  
12 
of the therapy of RSM disease be assessed according to levels of this protein 
/as it  is  in HIV posit ive patients, and success rate of the therapy assessment/?   
Relation of beta2-microglobulin level to gender is obvious in some groups.  
 
6. CONCLUSION 
The above given results show the importance and predicative value of beta2- 
microglobulin examination. 
Another research and elaboration of disputable questions in this area is to be 
considered.  
I assume the size of the file being examined provides a high predicative 
value.  
The examinations were carried out at  one work place, thus an error on 
processing individual samples is precluded.  
Examination of this protein does not require any special financial means and 
with respect to its predicative value it  should be considered fundamental 
cerebrospinal fluid examination in the future.  
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